NCT00540696 Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin Alfa Status COMPLETED Phase PHASE2
NCT00540657 A Phase II Study of CCX282-B in Patients With Celiac Disease Status COMPLETED Phase PHASE2
NCT00540384 Dose-finding Study of Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia in Subjects With Solid Tumours Receiving Multicycle Chemotherapy Status COMPLETED Phase PHASE1/PHASE2
NCT00540332 A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy Status WITHDRAWN Phase PHASE1/PHASE2
NCT00534456 An Exploratory Sub-study for the RED-HF™ (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial Status TERMINATED Phase PHASE3
NCT00534027 A Phase 1b/2 Study of AMG 655 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00531284 Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00530114 Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia Status COMPLETED Phase PHASE2
NCT00527267 Safety and Efficacy Study of AMG 073 in Hemodialysis Subjects Status COMPLETED Phase PHASE3
NCT00523341 Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis Status COMPLETED Phase PHASE3
NCT00521339 Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT00515463 A Multi-Center, Randomized, Open-Label Study to Assess the Immunogenicity and Safety of Denosumab in Pre-filled Syringe Compared to Vial in Subjects With Low Bone Mineral Density Status COMPLETED Phase PHASE3
NCT00515203 Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects Status COMPLETED Phase PHASE1/PHASE2